Scherrmann JM - Search Results

1

Expression and function of multidrug resistance transporters at the blood-brain barriers.

Scherrmann JM. Scherrmann JM. Expert Opin Drug Metab Toxicol. 2005 Aug;1(2):233-46. doi: 10.1517/17425255.1.2.233. Expert Opin Drug Metab Toxicol. 2005. PMID: 16922639 Review.

2

Microdialysis in mice for drug delivery research.

Boschi G, Scherrmann J. Boschi G, et al. Adv Drug Deliv Rev. 2000 Dec 15;45(2-3):271-81. doi: 10.1016/s0169-409x(00)00111-3. Adv Drug Deliv Rev. 2000. PMID: 11108979 Review.

3

[Cationization, a process for the delivery of antibodies to the central nervous system. Problems encountered in its application for immunotherapy strategies such as those for clostridial poisoning].

Hervé F, Ouzilou-Girod J, Scherrmann JM. Hervé F, et al. Among authors: scherrmann jm. J Soc Biol. 2001;195(3):201-27. J Soc Biol. 2001. PMID: 11833458 Review. French.

4

Study of uranium transfer across the blood-brain barrier.

Lemercier V, Millot X, Ansoborlo E, Ménétrier F, Flüry-Hérard A, Rousselle Ch, Scherrmann JM. Lemercier V, et al. Among authors: scherrmann jm. Radiat Prot Dosimetry. 2003;105(1-4):243-5. doi: 10.1093/oxfordjournals.rpd.a006232. Radiat Prot Dosimetry. 2003. PMID: 14526964

5

Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes.

Declèves X, Regina A, Laplanche JL, Roux F, Boval B, Launay JM, Scherrmann JM. Declèves X, et al. Among authors: scherrmann jm. J Neurosci Res. 2000 Jun 1;60(5):594-601. doi: 10.1002/(SICI)1097-4547(20000601)60:5<594::AID-JNR4>3.0.CO;2-6. J Neurosci Res. 2000. PMID: 10820430

6

Transport of cationized anti-tetanus Fab'2 fragments across an in vitro blood-brain barrier model: involvement of the transcytosis pathway.

Girod J, Fenart L, Régina A, Dehouck MP, Hong G, Scherrmann JM, Cecchelli R, Roux F. Girod J, et al. Among authors: scherrmann jm. J Neurochem. 1999 Nov;73(5):2002-8. J Neurochem. 1999. PMID: 10537059

7

Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability.

Stain-Texier F, Boschi G, Sandouk P, Scherrmann JM. Stain-Texier F, et al. Among authors: scherrmann jm. Br J Pharmacol. 1999 Oct;128(4):917-24. doi: 10.1038/sj.bjp.0702873. Br J Pharmacol. 1999. PMID: 10556926 Free PMC article.

8

P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells.

Declèves X, Chappey O, Boval B, Niel E, Scherrmann JM. Declèves X, et al. Among authors: scherrmann jm. Pharm Res. 1998 May;15(5):712-8. doi: 10.1023/a:1011914902121. Pharm Res. 1998. PMID: 9619779

9

Role of P-glycoprotein in colchicine and vinblastine cellular kinetics in an immortalized rat brain microvessel endothelial cell line.

El Hafny B, Cano N, Piciotti M, Regina A, Scherrmann JM, Roux F. El Hafny B, et al. Among authors: scherrmann jm. Biochem Pharmacol. 1997 Jun 1;53(11):1735-42. doi: 10.1016/s0006-2952(97)00093-2. Biochem Pharmacol. 1997. PMID: 9264327

10

Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice.

Cisternino S, Rousselle C, Dagenais C, Scherrmann JM. Cisternino S, et al. Among authors: scherrmann jm. Pharm Res. 2001 Feb;18(2):183-90. doi: 10.1023/a:1011080418027. Pharm Res. 2001. PMID: 11405289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results